Globus Medical (GMED) Depreciation & Amortization (CF) (2011 - 2026)

Globus Medical (GMED) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $69.9 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 6.4% year-over-year to $69.9 million; the trailing twelve-month figure through Mar 2026 stood at $281.0 million (up 6.54% YoY), and the FY2025 full-year result was $276.8 million, up 9.26% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $69.9 million, up from $69.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $72.0 million in Q4 2023 and bottomed at $16.8 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $63.6 million (2024), against an average of $47.9 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) slipped 11.52%; it then jumped 325.52% in 2023.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $16.9 million in 2022, then soared by 325.52% to $72.0 million in 2023, then decreased by 6.06% to $67.6 million in 2024, then gained by 2.1% to $69.0 million in 2025, then advanced by 1.22% to $69.9 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $69.9 million (Q1 2026), $69.0 million (Q4 2025), and $71.1 million (Q3 2025), per Business Quant data.

Peer Comparison